Mr. Edward C. Albini This is Me

Education

 View all 105 references Web References

1. 1. phx.corporate-ir.net

   phx.corporate-ir.net/phoenix.z - [Cached]

   Published on: 7/7/2008   Last Visited: 7/7/2008

   Edward C. AlbiniCorporate Governance - Biography - Novacea.com
   ...
   Edward C. AlbiniVice President and Chief Financial Officer
   
   Edward C. Albini has served as our Vice President and Chief Financial Officer since February 2004.From April 1997 to February 2004, Mr. Albini served as Chief Financial Officer at Lynx Therapeutics, Inc. (now Solexa Inc.), a biotechnology company.From January 1983 to April 1997, he served in various senior financial management positions at Genentech, including Director of Financial Planning and Analysis and Assistant Controller.He has also served as an auditor for Peat, Marwick, Mitchell & Co., now KPMG, LLP.Mr. Albini holds a B.S. in accounting from Santa Clara University and an M.B.A. from the Haas School of Business at the University of California at Berkeley.He is a certified public accountant.

2. 2. Novacea Press Releases – Novacea.com

   trials.novacea.com/610.asp?id= - [Cached]

   Published on: 4/11/2007   Last Visited: 7/7/2008

   SOUTH SAN FRANCISCO, CA - Novacea Inc., a privately-held biopharmaceutical company, announced today that Edward C. Albini has been appointed vice president and chief financial officer.Mr. Albini joins Novacea from Lynx Therapeutics, Inc., a publicly traded Bay Area-based biotechnology company."Ed is a senior financial executive with more than 20 years of biotechnology experience, including seven years at Lynx and more than 14 years in various financial management positions at Genentech," said Brad Goodwin, Novacea's chief executive officer.
   ...
   At Novacea, Albini will be responsible for oversight and management of all financial activities, including debt and equity financings, strategic financial evaluation, financial planning and control, and investor relations.As the chief financial officer at Lynx, Albini led equity and debt offerings that raised $75 million and negotiated revenue-bearing agreements for the company.Previously, he worked at Genentech in various senior financial management positions, including director of financial planning and analysis and assistant controller.Albini's financing experience at Genentech included significant roles in equity offerings that raised more than $90 million, as well as multiple R&D limited partnerships and a $150 million convertible debt issuance.Albini has also served as senior auditor for Peat, Marwick, Mitchell & Co., now KPMG, LLP.Albini has a bachelor of science degree in accounting from Santa Clara University and a master of business administration degree from the Haas School of Business at the University of California, Berkeley.He is a certified public accountant.

3. 3. Novacea Press Releases – Novacea.com

   www.novacea.com/610.asp?id=123 - [Cached]

   Published on: 6/22/2007   Last Visited: 4/2/2008

   "Joining the Russell 3000 Index marks an important corporate event for Novacea, as we continue to focus on delivering solid performance to our shareholders," said Edward Albini, Novacea's Vice President and Chief Financial Officer.